The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

18 Aug 2008 07:00

RNS Number : 4672B
Byotrol PLC
18 August 2008
 

Byotrol plc (the "Company")

Directors' Shareholdings

The Board announces that certain Directors, employees and associates of the Company have today in aggregate acquired 475,440 new ordinary shares through the exercise of warrants at a price of 23 pence per share. The Board have also been notified that certain other warrant holders have acquired in aggregate 1,855,000 new ordinary shares through the exercise of warrants, also at 23 pence per share, raising the Company a total of £536,001. 

The table below details the Directors who have exercised warrants and their resulting share holdings

Director 

Number of warrants exercised

Total beneficial holding post exercise

Total % holding of enlarged share capital post exercise

Number of warrants still held post exercise

Ian Mainman

60,600

363,600

0.77

0

Wesley Devoto

84,840

509,040

1.08

0

David McRobbie*

300,000

3,947,614

8.40

**284,523

Stephen Falder

-

5,058,581

10.76

***87,551

* The above total holding for David McRobbie includes 3,106,000 ordinary shares registered in the name of, and warrants over 261,200 ordinary shares held by, A.S. Technologies LLC, a company controlled by him.

** David McRobbie has assigned 145,000 warrants to family members and company associates whose exercises are included in this announcement.

*** Stephen Falder has assigned 870,000 warrants reducing his holding to 87,551; his beneficial shareholding in the Company remains unchanged. The assigned warrants have been exercised and are included in this announcement.

Accordingly, application has been made for the 2,330,440 new ordinary shares to be admitted to trading on AIM and it is expected that admission will take place on 20 August 2008.

The new ordinary shares will rank pari passu with the existing shares of the Company. Following this allotment, the total issued share capital of the Company will increase to 46,992,775 ordinary shares.

18 August 2008 

Contact: 

Byotrol Plc 

Richard Bell, Finance Director 

Tel 0161 277 9518

Charles Stanley Securities

(Nominated Adviser)

Philip Davies / Carl Holmes

Tel 020 7149 6000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKGGMRDKMGRZM
Date   Source Headline
30th Apr 20247:00 amRNSCancellation - Byotrol Plc
29th Apr 20242:15 pmRNSSecondary Trading on Asset Match
23rd Apr 20246:00 pmRNSByotrol
22nd Apr 20244:44 pmRNSCapital Reorganisation Delay
22nd Apr 20241:27 pmRNSResults of General Meeting
15th Apr 202411:48 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20243:27 pmRNSDirector Dealing
28th Mar 20247:00 amRNSProposed Cancellation
22nd Dec 202311:44 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSHalf-year Report
14th Nov 20237:00 amRNSLaunch of PROCESSUS® Instrument Decontamination
14th Nov 20237:00 amRNSTrading Update
9th Nov 20233:43 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSBoard Changes
13th Sep 20233:33 pmRNSResult of AGM
8th Sep 20234:33 pmRNSDirector Dealing
7th Sep 20237:01 amRNSBoard Appointment
7th Sep 20237:00 amRNSTrading Update
29th Aug 20238:51 amRNSLaunch of CHEMGENE MEDLAB into human healthcare
23rd Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSFinal Results
6th Jul 20237:00 amRNSPatent Grant for Novel Anti-viral Seaweed Extract
24th May 20233:14 pmRNSUS EPA approves Byotrol24 as long-lasting virucide
24th May 20238:51 amRNSDirector Dealing
28th Apr 20239:57 amRNSDirector Dealing
27th Apr 20237:00 amRNSTrading Update and Board Changes
1st Feb 20239:52 amRNSDirector Dealing
22nd Dec 20223:08 pmRNSDirector Dealing
19th Dec 202210:00 amRNSDirector Dealing
16th Dec 20227:00 amRNSGrant of Share Incentive Awards
12th Dec 20227:00 amRNSInterim results and Investor Presentation
22nd Nov 20227:00 amRNSDirectorate Changes
27th Sep 202211:15 amRNSPDMR Shareholding
22nd Sep 20225:21 pmRNSResult of AGM
8th Sep 20227:00 amRNSDirector Dealing
2nd Sep 202210:02 amRNSInvestor Presentation
30th Aug 20227:00 amRNSFinal Results
12th Aug 20223:30 pmRNSDirector Dealing
28th Jul 20227:00 amRNSCompletion of Convertible Loan Note Fundraising
11th Jul 20227:00 amRNSTrading Update and Notice of Results
22nd Apr 20229:14 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSTrading Update
12th Jan 20227:00 amRNSSenior Management Appointment
14th Dec 20219:06 amRNSSecond Price Monitoring Extn
14th Dec 20219:00 amRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSDirectorate Change
9th Dec 20218:51 amRNSDirector Dealing
8th Dec 20217:00 amRNSInterim Results and Investor Presentation
2nd Nov 20217:00 amRNSDirectorate and Senior Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.